Skip to main content
. 2012 Jan 27;7(1):e30690. doi: 10.1371/journal.pone.0030690

Figure 3. Effects of fluorescent CD44 mAb intravenously administered over three weeks on the bioluminescence signal of HL60-Luc tumor-bearing mice (A) and on life span (B).

Figure 3